Theragen Etex Co., Ltd.
Records under this name other than patents Theragen Etex Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 3 of 3 · Back to Theragen Etex Co., Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,427,547 | Edaravone Prodrug Compound and Pharmaceutical Use Thereof in Treatment or Alleviation of Neurodegenerative or Motor Neuron Disease Lapsed on the fee record Ended Aug 30, 2026 · High confidence | Lapsed on the fee record | Ended Aug 30, 2026 | High confidence |
| US 8,450,274 | DKK2 protein and use thereof Formerly held Lapsed on the fee record Ended May 28, 2025 · USPTO record | Lapsed on the fee record | Ended May 28, 2025 | USPTO record |
| US 8,067,387 | Method for Stimulating Angiogenesis Using DKK2 and Composition Comprising the Same Formerly held Lapsed on the fee record Ended Nov 29, 2023 · High confidence | Lapsed on the fee record | Ended Nov 29, 2023 | High confidence |